HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Georas, S. N. Search for Related Content PubMed PubMed Citation Articles by Georas, S. N.

Inhaled Glucocorticoids, Lymphocytes, and Dendritic Cells in Asthma and Obstructive Lung Diseases

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland

Correspondence and requests for reprints should be addressed to Steve N. Georas, M.D., Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Room 4B.41, Johns Hopkins Asthma & Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224. E-mail: sgeoras{at}jhmi.edu

Many of the therapeutic effects of systemic and inhaled corticosteroids can be explained by their ability to modulate immune responses. T lymphocytes in particular have been used to establish some of the key paradigms by which corticosteroids inhibit cell activation and gene expression, and there is now substantial evidence that inhaled corticosteroids potently suppress pulmonary immune responses driven by T-helper cells. Inhaled corticosteroids work in part by suppressing T-cell homing to the lung, but they also inhibit T-cell activation within the airways. This article reviews the mechanisms by which inhaled corticosteroids inhibit T-cell homing and activation, including the transcriptional pathways targeted by corticosteroids and the glucocorticoid receptor in T cells. Emerging data point to dendritic cells (DCs) as another cellular target of corticosteroids in the lung. DCs are a key component of the innate immune system, and subtle differences in DC maturation can qualitatively alter T-cell activation and a subsequent immune response. Thus, this article also reviews the mechanisms of DC maturation and DC:T cell cross-talk, including new evidence that corticosteroids might act at this level to inhibit antigen-specific immunity.

Key Words: asthma • chronic obstructive pulmonary disease • dendritic cell maturation • T-cell activation • T-cell homing

This article has been cited by other articles:

				C. Menge and E. A. Dean-Nystrom Dexamethasone Depletes {gamma}{delta}T Cells and Alters the Activation State and Responsiveness of Bovine Peripheral Blood Lymphocyte Subpopulations J Dairy Sci, June 1, 2008; 91(6): 2284 - 2298. [Abstract] [Full Text] [PDF]

				M. Tsoumakidou, W. Elston, J. Zhu, Z. Wang, E. Gamble, N. M. Siafakas, N. C. Barnes, and P. K. Jeffery Cigarette Smoking Alters Bronchial Mucosal Immunity in Asthma Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 919 - 925. [Abstract] [Full Text] [PDF]

				S. N. Georas, J. Guo, U. De Fanis, and V. Casolaro T-helper cell type-2 regulation in allergic disease Eur. Respir. J., December 1, 2005; 26(6): 1119 - 1137. [Abstract] [Full Text] [PDF]